Noshaq

A clinical-stage biotechnology company developing regenerative cell therapies and grafts to repair bone and other damaged tissues, including a pivotal-stage treatment for a rare pediatric bone disorder.

Amyl Therapeutics is developing immunotherapies that target amyloid aggregates linked to neurodegenerative disease.

Develops an off-the-shelf in vivo immunotherapy platform for solid tumors